US Stock MarketDetailed Quotes
ZEPP Zepp Health
- 0.740
- +0.010+1.30%
Close Aug 23 16:00 ET
- 0.740
- 0.000-0.04%
Post 20:02 ET
43.76MMarket Cap-1850P/E (TTM)
0.759High0.700Low40.02KVolume0.759Open0.731Pre Close29.22KTurnover0.19%Turnover RatioLossP/E (Static)59.13MShares2.10052wk High0.14P/B16.00MFloat Cap0.51552wk Low--Dividend TTM21.62MShs Float19.586Historical High--Div YieldTTM8.08%Amplitude0.515Historical Low0.730Avg Price1Lot Size
Zepp Health Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -56.04%40.64M | -56.95%40.36M | -41.38%352.02M | -45.60%92.21M | -51.23%82.52M | -44.10%92.45M | -21.27%93.75M | -38.76%600.48M | -37.58%169.5M | -31.82%169.21M |
| Operating revenue | -56.04%40.64M | -56.95%40.36M | -41.38%352.02M | -45.60%92.21M | -51.23%82.52M | -44.10%92.45M | -21.27%93.75M | -38.76%600.48M | -37.58%169.5M | -31.82%169.21M |
| Cost of revenue | -66.33%24.28M | -67.63%25.51M | -46.45%259.23M | -54.69%61.02M | -60.13%54.55M | -46.88%72.12M | -17.16%78.81M | -37.60%484.07M | -38.48%134.67M | -30.94%136.84M |
| Gross profit | -19.50%16.36M | -0.63%14.85M | -20.28%92.79M | -10.46%31.19M | -13.60%27.97M | -31.32%20.33M | -37.59%14.94M | -43.17%116.41M | -33.82%34.84M | -35.29%32.37M |
| Operating expense | -14.61%26.23M | -16.38%30.83M | -30.62%122.01M | -32.97%31.29M | -37.91%26.48M | -33.38%30.71M | -23.81%36.87M | -7.49%175.87M | -8.20%46.68M | 5.65%42.65M |
| Selling and administrative expenses | -14.12%15.41M | -12.26%17.32M | -29.67%70.97M | -33.20%18.87M | -34.40%16.25M | -33.18%17.94M | -22.16%19.74M | -7.66%100.91M | -19.61%28.25M | 5.07%24.78M |
| -Selling and marketing expense | 3.34%10.56M | -13.04%10.86M | -33.49%44.38M | -33.35%13.11M | -44.35%9.67M | -36.77%10.21M | -22.96%12.49M | -2.97%66.72M | -19.81%19.68M | 24.01%17.38M |
| -General and administrative expense | -37.19%4.85M | -10.93%6.46M | -22.23%26.59M | -32.83%5.76M | -11.02%6.58M | -27.77%7.73M | -20.74%7.25M | -15.63%34.2M | -19.16%8.58M | -22.67%7.4M |
| Research and development costs | -15.29%10.82M | -21.13%13.51M | -31.90%51.04M | -32.63%12.42M | -42.77%10.23M | -33.65%12.77M | -25.62%17.13M | -7.25%74.95M | 17.32%18.43M | 6.46%17.88M |
| Operating profit | 5.03%-9.87M | 27.11%-15.98M | 50.86%-29.22M | 99.16%-99.96K | 114.45%1.49M | 37.06%-10.39M | 10.31%-21.93M | -503.45%-59.46M | -766.59%-11.85M | -206.49%-10.28M |
| Net non-operating interest income expense | 53.19%-425K | 67.42%-434.78K | 43.81%-3.64M | 61.63%-711.08K | 52.13%-794.66K | 49.18%-908K | 6.99%-1.33M | -46.35%-6.47M | -0.15%-1.85M | -8.34%-1.66M |
| Non-operating interest income | 11.79%948K | 70.27%1.02M | 72.95%3.09M | 34.98%904.7K | 75.70%805.76K | 164.58%848K | 49.91%600.56K | -31.71%1.79M | 39.24%670.26K | -16.94%458.6K |
| Non-operating interest expense | -21.81%1.37M | -24.69%1.46M | -18.55%6.73M | -35.97%1.62M | -24.46%1.6M | -16.67%1.76M | 5.43%1.94M | 17.33%8.26M | 8.22%2.52M | 1.64%2.12M |
| Other net income (expense) | -140.33%-173K | 996.87%2.19M | -104.60%-549.47K | -186.67%-955.99K | -104.49%-194.48K | 131.67%429K | -97.71%199.94K | 85.96%11.94M | -70.28%1.1M | 1,508.74%4.33M |
| Gain on sale of security | -155.45%-300K | 334.99%2.12M | -96.24%285.81K | -124.72%-737.05K | 104.09%42.49K | 131.81%541K | -93.99%488.38K | 258.51%7.6M | 9,239.50%2.98M | ---1.04M |
| Special income (charges) | ---- | ---- | 84.11%-319.24K | ---- | ---- | ---- | ---- | ---2.01M | ---- | ---- |
| -Write off | ---- | ---- | -84.11%319.24K | ---- | ---- | ---- | ---- | --2.01M | ---- | ---- |
| Other non- operating income (expenses) | 213.39%127K | 123.82%68.72K | -108.12%-516.04K | -22.80%100.31K | -104.41%-236.97K | -132.35%-112K | -148.97%-288.44K | 47.66%6.35M | -96.47%129.93K | 1,895.10%5.37M |
| Income before tax | 3.71%-10.46M | 38.32%-14.22M | 38.14%-33.4M | 85.97%-1.77M | 106.53%496.7K | 44.69%-10.87M | -34.38%-23.06M | -422.66%-54M | -446.29%-12.6M | -190.70%-7.61M |
| Income tax | 102.84%47K | 102.01%72.23K | 76.62%-2.23M | 509.74%2.68M | 101.38%65.1K | 14.75%-1.66M | -36.44%-3.59M | -666.41%-9.55M | -731.53%-655.14K | -589.96%-4.72M |
| Earnings from equity interest net of tax | 60.63%-337K | -32.57%-564.62K | -53.80%1.18M | 13,588.20%2.46M | -110.51%-50.3K | -150.10%-856K | -177.19%-425.9K | -60.24%2.56M | -100.77%-18.22K | 210.84%478.39K |
| Net income | -7.76%-10.85M | 25.30%-14.86M | 28.41%-29.99M | 83.33%-1.99M | 115.78%381.29K | 37.06%-10.07M | -42.34%-19.89M | -294.96%-41.89M | -302.44%-11.96M | -131.87%-2.42M |
| Net income continuous Operations | -7.76%-10.85M | 25.30%-14.86M | 28.41%-29.99M | 83.33%-1.99M | 115.78%381.29K | 37.06%-10.07M | -42.34%-19.89M | -294.96%-41.89M | -302.44%-11.96M | -131.87%-2.42M |
| Minority interest income | 61.54%-10K | -15.15%-32.46K | 34.69%-65.6K | 141.88%12.8K | -48.42%-26.45K | 26.48%-26K | -33.75%-28.19K | 24.77%-100.44K | -8.06%-30.56K | 58.51%-17.82K |
| Net income attributable to the parent company | -7.94%-10.84M | 25.36%-14.83M | 28.39%-29.92M | 83.18%-2.01M | 117.00%407.75K | 37.08%-10.04M | -42.36%-19.87M | -293.29%-41.79M | -300.96%-11.93M | -131.45%-2.4M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -7.94%-10.84M | 25.36%-14.83M | 28.39%-29.92M | 83.18%-2.01M | 117.00%407.75K | 37.08%-10.04M | -42.36%-19.87M | -293.29%-41.79M | -300.96%-11.93M | -131.45%-2.4M |
| Basic earnings per share | 0.00%-0.16 | 29.20%-0.2305 | 27.63%-0.4909 | 90.58%-0.0169 | 113.95%0.0055 | 39.07%-0.16 | -43.71%-0.3255 | -296.53%-0.6783 | -304.57%-0.1797 | -131.79%-0.0393 |
| Diluted earnings per share | 0.00%-0.16 | 29.20%-0.2305 | 27.63%-0.4909 | 90.58%-0.0169 | 113.95%0.0055 | 39.07%-0.16 | -43.71%-0.3255 | -307.87%-0.6783 | -304.57%-0.1797 | -133.46%-0.0393 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg